Cargando…
Cyclosporine A to Treat Unexplained Recurrent Spontaneous Abortions: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Single-Center Trial
BACKGROUND: The World Health Organization (WHO) has defined Unexplained Recurrent Spontaneous Abortion (URSA) as three and more consecutive miscarriages before the 20th week of gestation. To date, empiric therapy for patients with unexplained recurrent pregnancy loss (URPL) is not precise. Studies h...
Autores principales: | Wang, Nan, Ge, Hongshan, Zhou, Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670855/ https://www.ncbi.nlm.nih.gov/pubmed/34916855 http://dx.doi.org/10.2147/IJWH.S330921 |
Ejemplares similares
-
Noncoding RNAs in Unexplained Recurrent Spontaneous Abortions and Their Diagnostic Potential
por: Jia, Ningyi, et al.
Publicado: (2019) -
Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
por: Liu, Sudong, et al.
Publicado: (2021) -
Polymorphisms in the Estrogen Receptor Beta Gene and the Risk of Unexplained Recurrent Spontaneous Abortion
por: Mahdavipour, Marzieh, et al.
Publicado: (2017) -
The alteration and potential relationship of vaginal microbiota and chemokines for unexplained recurrent spontaneous abortion
por: Fan, Tao, et al.
Publicado: (2020) -
Apoptosis and p53 expression in the placental villi of females with unexplained recurrent spontaneous abortion
por: WEI, DEHUA, et al.
Publicado: (2014)